WATERTOWN, Mass.--(BUSINESS WIRE)--SQZ Biotechnologies (NYSE: SQZ) announced today that the company’s first generation, integrated point-of-care (POC) cell therapy manufacturing system demonstrated ...

By enabling the creation of modular workcells and lot-of-one production, AMRs are the key to replacing linear assembly lines ...

The biopharmaceutical industry is undergoing a structural shift. For decades, contract development and manufacturing organisations (CDMOs) have operated through fragmented models, with drug substance ...

Although estimates vary slightly, many industry experts predict continuous manufacturing will, at the least, cut the cost of manufacturing biologics in half. Thus, it will be an attractive option for ...

Precision Solutions for Semiconductors and Electronics The semiconductor industry represents the pinnacle of precision ...

Sanmina to Host Conference Call Today at 8:30 a.m. ET (5:30 a.m. PT) Mr. Sola continued, "We look forward to welcoming the ZT Systems team to Sanmina and realizing the benefits of this highly ...

Pharmaceutical manufacturing steps are often isolated in space and time. The synthesis, isolation and purification of the drug substance (DS) and the formulation of the drug product (DP) may be ...

Budget 2026 becomes significant as a prospective policy window that can help strengthen the shift of India as a scale-based growing economy towards technology-based, high value production.